Package Leaflet: Information for the User
Salmeterol/Fluticasone Cipla 25 micrograms/250 micrograms/inhalation, suspension for inhalation in a pressurized container
salmeterol/fluticasone propionate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
Salmeterol/Fluticasone Cipla contains two active substances, salmeterol and fluticasone propionate:
Your doctor has prescribed this medicine to help prevent breathing problems such as asthma.
You should use Salmeterol/Fluticasone Cipla every day, as your doctor has recommended. This will ensure that the medicine works correctly to control your asthma.
Salmeterol/Fluticasone Cipla helps to prevent shortness of breath and wheezing. However, Salmeterol/Fluticasone Cipla should not be used to relieve a sudden attack of shortness of breath or wheezing. In such cases, you should use your "rescue" medication, such as salbutamol. You should always carry your quick-acting rescue medication with you.
Do not use Salmeterol/Fluticasone Cipla
If you are allergic (hypersensitive) to salmeterol, fluticasone propionate, or any of the other ingredients of this medicine.
Warnings and precautions
Your doctor will monitor your treatment more closely if you have any of the following conditions:
If you have had any of these conditions, tell your doctor before using Salmeterol/Fluticasone Cipla.
Using Salmeterol/Fluticasone Cipla with other medicines
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription. This is because, in some cases, Salmeterol/Fluticasone Cipla should not be used with other medicines.
Tell your doctor if you are taking any of the following medicines before starting to use Salmeterol/Fluticasone Cipla:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
Salmeterol/Fluticasone Cipla is unlikely to affect your ability to drive or use machines.
Follow the instructions for using this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist again.
Adults and adolescents 12 years and older
Children under 12 years of age
Your symptoms may be well-controlled using Salmeterol/Fluticasone Cipla twice daily. If this is the case, your doctor may decide to reduce your dose to once daily. The dose may be changed to:
It is very important that you follow your doctor's instructions on how many inhalations to take and how often to take them.
If you are using Salmeterol/Fluticasone Cipla to treat asthma, your doctor will want to monitor your symptoms regularly.
If your asthma gets worse or you have more difficulty breathing, see your doctor immediately. You may notice more wheezing or shortness of breath more often, or you may need to use your quick-acting rescue medication more frequently. If any of these things happen, you should continue to use Salmeterol/Fluticasone Cipla, but do not increase the number of inhalations. Your lung disease may be getting worse, and you may become seriously ill. See your doctor, as you may need additional treatment.
Instructions for use
Each time you activate the inhaler, one inhalation is released, and the counter decreases by one.
Checking the inhaler
Using the inhaler
It is important to start breathing in as slowly as possible just before using your inhaler.
Do not put the metal canister in water.
If you use more Salmeterol/Fluticasone Cipla than you should
It is very important to use the inhaler as directed. If you accidentally take a higher dose than recommended, talk to your doctor or pharmacist. You may notice that your heart beats faster than normal, and you may feel shaky. You may also get a headache, feel dizzy, weak, or have muscle pain.
If you have used high doses for long periods, you should ask your doctor or pharmacist for advice. This is because high levels of Salmeterol/Fluticasone Cipla may reduce the amount of steroid hormones produced by the adrenal gland.
In case of overdose, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, stating the medicine and the amount taken.
If you forget to use Salmeterol/Fluticasone Cipla
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
If you stop using Salmeterol/Fluticasone Cipla
It is very important that you use Salmeterol/Fluticasone Cipla every day, as directed. Continue to use it until your doctor tells you to stop. Do not stop using Salmeterol/Fluticasone Cipla suddenly.This could make your breathing worse.
Also, if you stop taking Salmeterol/Fluticasone Cipla suddenly or reduce your dose, you may (very rarely) get problems with your adrenal gland (adrenal insufficiency), which can sometimes cause side effects.
These side effects may include:
When your body is under stress, such as during fever, injury (e.g., car accident), infection, or surgery, adrenal insufficiency may worsen, and you may get any of the above side effects.
If you get any side effects, talk to your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe a higher dose of corticosteroids in tablets during this time (such as prednisolone).
If you have any further questions on the use of this medicine, ask your doctor, nurse, or pharmacist.
Like all medicines, this medicine may cause adverse effects, although not all people suffer from them. To reduce the appearance of adverse effects, your doctor will prescribe the lowest dose of Salmeterol/Fluticasona Cipla that controls your asthma.
Allergic Reactions: you may notice that your breathing suddenly worsens immediately after using Salmeterol/Fluticasona Cipla.You may suffer from wheezing and coughing or shortness of breath. You may also notice itching, rash (urticaria), and swelling (usually of the face, lips, tongue, or throat). You may also suddenly feel that your heart is beating very fast, feel like you are losing consciousness, and dizziness (which can lead to collapse or loss of consciousness). If you experience any of these effects or if they appear suddenly after using Salmeterol/Fluticasona Cipla, stop taking Salmeterol/Fluticasona Cipla and inform your doctor immediately. Allergic reactions to Salmeterol/Fluticasona Cipla are rare (affect less than 1 in 100 people).
The following are other adverse effects:
Very Common (may affect more than 1 in 10 people)
Common (may affect less than 1 in 10 people)
The following adverse effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
Uncommon (may affect less than 1 in 100 people)
Rare (may affect less than 1 in 1,000 people)
Frequency not known, but may also occur:
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use Salmeterol/Fluticasona Cipla Inhaler after the expiration date stated on the label and carton after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
The cartridge contains pressurized liquid. Do not expose to temperatures above 50°C, protect from direct sunlight. Do not pierce or burn the cartridge even if it is empty.
As with most pressurized inhalation medicines, the therapeutic effect may decrease if the cartridge is cooled.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Salmeterol/Fluticasona Cipla
Each pressurized dose contains: 25 micrograms of salmeterol (as salmeterol xinafoate) and 250 micrograms of fluticasone propionate.
This medicine contains fluorinated greenhouse gases.
Each inhaler contains 12.5 g of HFC-134a (norflurane) which corresponds to 0.018 tons of CO2 equivalent (global warming potential GWP = 1430).
Appearance of the Product and Package Contents
Marketing Authorization Holder and Manufacturer
Cipla Europe NV
De Keyserlei 60C, Bus-1301,
2018 Antwerp
Belgium
Local Representative
Cipla Europe NV, Spanish branch,
C/ Guzmán el Bueno, 133 Edif Britannia-28003- Madrid
Date of Last Revision of this Leaflet:January 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of SALMETEROL/FLUTICASONE CIPLA 25 micrograms/250 micrograms INHALATION SUSPENSION in pressurized container in October, 2025 is around 41.28 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.